Clean Tech Nation

Randstad Sourceright Partners with Scoping and Statement of Work Authoring Platform Deployed

Retrieved on: 
Wednesday, September 28, 2022

LONDON, Sept. 28, 2022 /PRNewswire/ -- Global talent solutions leader Randstad Sourceright is pleased to announce its partnership with Deployed – a Scoping and Statement of Work (SOW) authoring software platform – to deliver 'Services Procurement 360', a statement of work management service that allows business leaders to strengthen the link between talent acquisition and the utilization of project-based expertise.

Key Points: 
  • "Randstad Sourceright is committed to transforming the way that our clients can leverage and deploy their total workforce," said Mike Smith, global CEO of Randstad Sourceright.
  • Kayleigh Kuptz, co-founder of Deployed commented: "We're delighted to be partnering with Randstad Sourceright to deliver this innovative statement of work assessment solution.
  • Deployed is rewriting the language of work with our unique scope authoring platform for projects that start smarter and finish stronger.
  • Deployed is project Scoping and Statement of Work authoring platform that streamlines the process of defining the work to be done for any services projects.

Akanda’s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK

Retrieved on: 
Wednesday, June 29, 2022

Phlo Connect offers a 120-minute delivery service in London and Birmingham and next-day delivery across the UK.

Key Points: 
  • Phlo Connect offers a 120-minute delivery service in London and Birmingham and next-day delivery across the UK.
  • This process will be increasingly seamless for patients in the near future as Phlo Connect, Leva Clinic, and CanMart build additional digital interconnections.
  • Patients can arrange a specialist consultation at www.levaclinic.com and seamlessly connect to Phlo Connects smartphone app to arrange medical cannabis delivery.
  • We believe partnering with CanMart and Cellen will be a game-changer for medicinal cannabis patients here in the UK.